CND Life Sciences Revenue and Competitors
Estimated Revenue & Valuation
- CND Life Sciences's estimated annual revenue is currently $10.5M per year.
- CND Life Sciences's estimated revenue per employee is $155,000
Employee Data
- CND Life Sciences has 68 Employees.
- CND Life Sciences grew their employee count by 13% last year.
CND Life Sciences's People
Name | Title | Email/Phone |
---|---|---|
1 | VP, Finance & Strategy | Reveal Email/Phone |
2 | Director Brand Marketing | Reveal Email/Phone |
3 | Human Resources Director | Reveal Email/Phone |
4 | Director, Clinical Services | Reveal Email/Phone |
5 | Director IT | Reveal Email/Phone |
6 | Laboratory Director | Reveal Email/Phone |
7 | Chief Pathologist and Medical Director | Reveal Email/Phone |
8 | Clinical Program Manager | Reveal Email/Phone |
9 | Market Development Manager - Cognitive Disorders | Reveal Email/Phone |
10 | Senior Quality Manager | Reveal Email/Phone |
CND Life Sciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.8M | 5 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $0.8M | 5 | -29% | N/A | N/A |
#4 | $5.3M | 34 | 0% | N/A | N/A |
#5 | $2.5M | 16 | -20% | N/A | N/A |
#6 | $1.1M | 7 | 0% | N/A | N/A |
#7 | $0.9M | 6 | 0% | N/A | N/A |
#8 | $2.2M | 29 | 21% | $58.2M | N/A |
#9 | $171.9M | 1109 | -3% | N/A | N/A |
#10 | $0.9M | 6 | 0% | N/A | N/A |
What Is CND Life Sciences?
CND Life Sciences is dedicated to supporting the care of patients suffering from neurodegenerative diseases and other conditions. Operating a CLIA-certified laboratory in Phoenix, AZ, CND launched the Syn-One Testâ„¢ as the first commercially available test to detect, visualize, and quantify the presence of abnormal, phosphorylated alpha-synuclein in cutaneous nerve fibers. The test serves as an objective diagnostic tool to aid in the confirmation of synucleinopathy in patients with suspected Parkinson's disease (PD), dementia with Lewy body (DLB), multiple system atrophy (MSA), or pure autonomic failure (PAF). Through analysis of three small punch skin biopsies provided by a referring physician, CND offers a convenient, accurate, minimally invasive alternative to aid in the diagnosis of neurodegenerative diseases. The company has research collaborations with multiple biopharmaceutical companies and is committed to advancing science in the field.
keywords:N/AN/A
Total Funding
68
Number of Employees
$10.5M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CND Life Sciences News
Founded in 2017, CND Life Sciences is dedicated to supporting the care of patients facing the potential diagnosis of a neurodegenerative disease...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $20.1M | 68 | 6% | N/A |
#2 | $8.9M | 68 | 62% | N/A |
#3 | $15.4M | 68 | 31% | N/A |
#4 | $6.1M | 68 | 31% | N/A |
#5 | $15.4M | 68 | 10% | N/A |